Korro Bio, Inc. — Director's Dealing 2024

Apr 24, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Korro Bio, Inc. (KRRO)
CIK: 0001703647
Period of Report: 2024-04-22

Reporting Person: New Enterprise Associates 17, L.P. (N/A)
Reporting Person: NEA Partners 17, L.P. (N/A)
Reporting Person: NEA 17 GP, LLC (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-04-22	Common Stock	P	17857	$56	Acquired	1090793	Direct

Footnotes

F1: Acquired from the Issuer on April 22, 2024 pursuant to a Subscription Agreement dated April 17, 2024.

F2: The securities are directly held by New Enterprise Associates 17, L.P. ("NEA 17") and are indirectly held by NEA Partners 17, L.P. ("NEA Partners 17"), the sole general partner of NEA 17, NEA 17 GP, LLC ("NEA 17 GP"), the sole general partner of NEA Partners 17, and the individual managers of NEA 17 GP (NEA Partners 17, NEA 17 GP and the individual managers of NEA 17 GP (collectively, the "Managers") together, the "Indirect Reporting Persons"). The Mangers are Forest Baskett, Ali Behbahani, Carmen Chang, Anthony Florence, Jr., Mohamad Makhzoumi, Edward Mathers, Scott Sandell, Paul Walker and Rick Yang. The Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 17 in which the Indirect Reporting Persons have no pecuniary interest.